TS
ORTX

Thomas Steyer’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Thomas Steyer’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-66,520
Closed -$1.53M – 321
2021
Q3 		$1.53M Sell
66,520
-255,023
-79% -$7.59M 0.01% 214
2021
Q2 		$14.1M Hold
321,543
– – 0.06% 117
2021
Q1 		$23.3M Buy
+321,543
New +$22.8M 0.12% 100

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Thomas Steyer's ORTX Position: Q4 2021 in Review

Thomas Steyer sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 66,520 shares — an estimated $1.53M sold.

Thomas Steyer first reported a position in ORTX in Q1 2021 and held it in 3 quarters. The position peaked at $23.3M in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Thomas Steyer reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Thomas Steyer sold 66,520 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $1.53M.
  • Thomas Steyer first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Thomas Steyer's Orchard Therapeutics plc American Depositary Shares position peaked at $23.3M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Farallon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.